NO20031860L - Kahalalid F - Google Patents
Kahalalid FInfo
- Publication number
- NO20031860L NO20031860L NO20031860A NO20031860A NO20031860L NO 20031860 L NO20031860 L NO 20031860L NO 20031860 A NO20031860 A NO 20031860A NO 20031860 A NO20031860 A NO 20031860A NO 20031860 L NO20031860 L NO 20031860L
- Authority
- NO
- Norway
- Prior art keywords
- kahalalid
- kahalalide
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Carbon And Carbon Compounds (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24447100P | 2000-10-31 | 2000-10-31 | |
US24622900P | 2000-11-06 | 2000-11-06 | |
US34844901P | 2001-10-19 | 2001-10-19 | |
PCT/GB2001/004821 WO2002036145A2 (en) | 2000-10-31 | 2001-10-31 | Kahalalide f formulation |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20031860D0 NO20031860D0 (no) | 2003-04-25 |
NO20031860L true NO20031860L (no) | 2003-06-30 |
NO331082B1 NO331082B1 (no) | 2011-10-03 |
Family
ID=27399760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031860A NO331082B1 (no) | 2000-10-31 | 2003-04-25 | Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft |
Country Status (22)
Country | Link |
---|---|
US (1) | US7473681B2 (no) |
EP (1) | EP1330258B1 (no) |
JP (2) | JP2004512370A (no) |
KR (1) | KR100834138B1 (no) |
CN (1) | CN1568192A (no) |
AT (1) | ATE314084T1 (no) |
AU (2) | AU2002210749B2 (no) |
BR (1) | BR0114912A (no) |
CA (1) | CA2425627A1 (no) |
CY (1) | CY1105009T1 (no) |
CZ (1) | CZ20031211A3 (no) |
DE (1) | DE60116359T2 (no) |
DK (1) | DK1330258T3 (no) |
ES (1) | ES2256305T3 (no) |
HK (1) | HK1054192B (no) |
HU (1) | HUP0600031A3 (no) |
IL (2) | IL155297A0 (no) |
MX (1) | MXPA03003704A (no) |
NO (1) | NO331082B1 (no) |
NZ (1) | NZ525243A (no) |
SK (1) | SK286421B6 (no) |
WO (1) | WO2002036145A2 (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0002952D0 (en) * | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
AU2002334203C1 (en) * | 2001-10-19 | 2008-10-09 | Pharma Mar, S.A. | Kahalalide compounds for use in cancer therapy |
US20050054555A1 (en) * | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
ATE490975T1 (de) * | 2002-10-18 | 2010-12-15 | Pharma Mar Sau | 4-methylhexanoic kahalalide f verbindung |
GB0304367D0 (en) * | 2003-02-26 | 2003-04-02 | Pharma Mar Sau | Methods for treating psoriasis |
MXPA05004133A (es) * | 2002-10-18 | 2005-10-05 | Pharma Mar Sau | Nuevos compuestos antitumorales. |
US7507708B2 (en) | 2003-02-26 | 2009-03-24 | Pharma Mar, S.A.U. | Antitumoral compounds |
DE10329847A1 (de) * | 2003-07-02 | 2005-01-20 | Toximed Gmbh | Pharmazeutischer Wirkstoff gegen Prostatakarzinome |
GB0321066D0 (en) | 2003-09-09 | 2003-10-08 | Pharma Mar Sau | New antitumoral compounds |
GB0408958D0 (en) * | 2004-04-22 | 2004-05-26 | Pharma Mar Sa | Convergent synthesis for kahalalide compounds |
PT1827500E (pt) * | 2004-10-26 | 2009-08-05 | Pharma Mar Sa | Doxorrubicina pegilada lipossomal em combinação com ecteinescidina 743 |
PT1658848E (pt) * | 2004-10-29 | 2007-11-05 | Pharma Mar Sa | Formulações contendo ecteinascidina e um dissacarídeo |
GB0522082D0 (en) * | 2005-10-31 | 2005-12-07 | Pharma Mar Sa | Formulations |
CA2703720A1 (en) * | 2007-10-19 | 2009-04-23 | Albert Einstein College Of Medicine Of Yeshiva University | Improved antitumoral treatments |
CA2713459A1 (en) * | 2008-01-30 | 2009-08-06 | Pharma Mar, S.A. | Improved antitumoral treatments |
AU2009221120A1 (en) * | 2008-03-07 | 2009-09-11 | Pharma Mar, S.A. | Improved antitumoral treatments |
WO2009135939A2 (en) * | 2008-05-09 | 2009-11-12 | Pharma Mar, S.A. | Depsipeptide for use in cancer therapy |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
JP2799483B2 (ja) | 1988-03-09 | 1998-09-17 | 大塚製薬株式会社 | インターロイキン−1β組成物の安定化方法 |
GB8819607D0 (en) * | 1988-08-17 | 1988-09-21 | Wellcome Found | Novel combination |
IE64738B1 (en) | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
JP2971680B2 (ja) | 1991-10-02 | 1999-11-08 | 山之内製薬株式会社 | 組織プラスミノーゲン活性化因子含有組成物 |
JPH0597703A (ja) | 1991-10-04 | 1993-04-20 | Yamanouchi Pharmaceut Co Ltd | 改変型組織プラスミノーゲン活性化因子含有組成物 |
US5550124A (en) | 1991-12-10 | 1996-08-27 | University Of Southern California | Use of peripheral-type benzodiazpine sites for treatment of CNS trauma or disease |
US5849704A (en) * | 1991-12-20 | 1998-12-15 | Novo Nordisk A/S | Pharmaceutical formulation |
GB9302046D0 (en) | 1993-02-03 | 1993-03-24 | Pharma Mar Sa | Antiumoral compound-v |
US6274551B1 (en) * | 1994-02-03 | 2001-08-14 | Pharmamar, S.A. | Cytotoxic and antiviral compound |
JP3927248B2 (ja) | 1995-07-11 | 2007-06-06 | 第一製薬株式会社 | Hgf凍結乾燥製剤 |
GB9601120D0 (en) | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
JPH1014581A (ja) | 1996-07-08 | 1998-01-20 | Morinaga Milk Ind Co Ltd | ウサギ型マクロファージ・コロニー刺激因子及びこれをコードするdna断片 |
EP0827751B1 (en) | 1996-09-06 | 2003-02-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Medicinal composition containing tissue plasminogen activator and nicotinamide |
JP4025394B2 (ja) * | 1996-09-06 | 2007-12-19 | 財団法人化学及血清療法研究所 | 組織プラスミノーゲン活性化因子医薬組成物 |
GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
GB9807639D0 (en) | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
CN1322136A (zh) | 1998-09-23 | 2001-11-14 | 马库斯·基普 | 用于选择性神经元辐射防护的神经亲免素类物质 |
GB0002952D0 (en) | 2000-02-09 | 2000-03-29 | Pharma Mar Sa | Process for producing kahalalide F compounds |
US20050054555A1 (en) | 2001-10-19 | 2005-03-10 | Jose Jimeno | Kahalalide compounds for use in cancer therapy |
-
2001
- 2001-10-31 AU AU2002210749A patent/AU2002210749B2/en not_active Ceased
- 2001-10-31 AT AT01978654T patent/ATE314084T1/de active
- 2001-10-31 EP EP01978654A patent/EP1330258B1/en not_active Expired - Lifetime
- 2001-10-31 BR BR0114912-1A patent/BR0114912A/pt active Search and Examination
- 2001-10-31 CA CA002425627A patent/CA2425627A1/en not_active Abandoned
- 2001-10-31 WO PCT/GB2001/004821 patent/WO2002036145A2/en active IP Right Grant
- 2001-10-31 ES ES01978654T patent/ES2256305T3/es not_active Expired - Lifetime
- 2001-10-31 DE DE60116359T patent/DE60116359T2/de not_active Expired - Lifetime
- 2001-10-31 MX MXPA03003704A patent/MXPA03003704A/es active IP Right Grant
- 2001-10-31 AU AU1074902A patent/AU1074902A/xx active Pending
- 2001-10-31 CZ CZ20031211A patent/CZ20031211A3/cs unknown
- 2001-10-31 KR KR1020037005347A patent/KR100834138B1/ko not_active IP Right Cessation
- 2001-10-31 US US10/399,571 patent/US7473681B2/en not_active Expired - Fee Related
- 2001-10-31 CN CNA018182712A patent/CN1568192A/zh active Pending
- 2001-10-31 SK SK502-2003A patent/SK286421B6/sk not_active IP Right Cessation
- 2001-10-31 DK DK01978654T patent/DK1330258T3/da active
- 2001-10-31 NZ NZ525243A patent/NZ525243A/en unknown
- 2001-10-31 IL IL15529701A patent/IL155297A0/xx unknown
- 2001-10-31 HU HU0600031A patent/HUP0600031A3/hu unknown
- 2001-10-31 JP JP2002538956A patent/JP2004512370A/ja active Pending
-
2003
- 2003-04-08 IL IL155297A patent/IL155297A/en not_active IP Right Cessation
- 2003-04-25 NO NO20031860A patent/NO331082B1/no not_active IP Right Cessation
- 2003-09-10 HK HK03106441.9A patent/HK1054192B/zh not_active IP Right Cessation
-
2006
- 2006-03-24 CY CY20061100415T patent/CY1105009T1/el unknown
-
2009
- 2009-10-23 JP JP2009244772A patent/JP2010047601A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20031860L (no) | Kahalalid F | |
TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
DE60010098D1 (de) | 28-epirapaloge | |
MXPA03005769A (es) | Politrimetilen eter ester amida y uso de la misma. | |
DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
UY34152A (es) | ?oxazolidinonas substituidas y su uso?. | |
ATE330017T1 (de) | Kallikrein gen | |
DOP2001000219A (es) | Applicator | |
BR0110577A (pt) | Decorina transgenicamente produzida | |
ATE420925T1 (de) | Silikonkautschukformulierungen und deren verwendung | |
AU144678S (en) | Bottle | |
AR030853A1 (es) | Composicion plaguicida | |
DE60114039D1 (de) | Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere | |
MXPA02007173A (es) | Compuestos calciliticos. | |
NO20005548L (no) | Mykobakterieinhibitorer | |
DE60124148D1 (de) | Kalzilytische verbindungen | |
BR0316544A (pt) | Compostos calcilìticos | |
TR200103662T2 (tr) | Yeni kalpainler ve bunların kullanılması | |
ATE433953T1 (de) | Peptiddeformylaseinhibitoren | |
UA50030A (uk) | Комплексне добриво | |
ES1049942Y (es) | Pareja de zocalo y portalamparas. | |
AU144369S (en) | Tube applicator | |
BR8002983U (pt) | Beliche guarda-roupa e escrivaninha | |
JO2151B1 (en) | Toilet (T.S) | |
BR8002856U (pt) | Televisão relógio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |